Molecular modeling of tricyclic compounds with anilino substituents and their intercalation complexes with DNA sequences

Journal of Molecular Graphics and Modelling

Volumn 27, Issue 8, 2009, Pages 900-907

  Loza Mejía, Marco A ^a   Castillo, Rafael ^a   Lira Rocha, Alfonso ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acridines; DNA; Docking; Imidazo 4,5 b quinolines; Intercalation complexes; Thiazolo 5,4 b quinolines; Tricyclic compounds

Indexed keywords

BENZENE; BINDING ENERGY; CYTOTOXICITY; DNA; DOCKING; ELECTROSTATICS; INTERCALATION COMPOUNDS; MOLECULAR MODELING;

ACRIDINES; IMIDAZO[4,5-B]QUINOLINES; INTERCALATION COMPLEXES; THIAZOLO[5,4-B]QUINOLINES; TRICYCLIC COMPOUNDS;

DNA SEQUENCES;

ACRIDINE DERIVATIVE; ANILINE DERIVATIVE; BENZENE;

ARTICLE; BASE PAIRING; BINDING AFFINITY; DIPOLE; DNA SEQUENCE; DRUG CONFORMATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; INTERCALATION COMPLEX; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL;

EID: 67349230449     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2009.02.001     Document Type: Article

References (37)

1. Fox K.R., and Waring M.J. Footprinting at low temperatures: evidence that ethidium and other simple intercalators can discriminate between different nucleotide sequences. Nucl. Acids Res. 15 (1987) 491-507
2. Pommier Y., Pourquier P., Fan Y., and Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400 (1998) 83-105
3. Burden D.A., and Osheroff N. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400 (1998) 139-154
4. Denny W.A. In: Foye W.O. (Ed). Cancer Chemotherapeutic Agents (1995), American Chemical Society, USA 218-239
5. Baguley B.C., Denny W.A., Atwell G.J., Finlay G.J., Rewcastle G.W., Twigden S.J., Wilson W.R., and Synthesis. antitumor activity, and DNA binding properties of a new derivative of Amsacrine, N-5-Dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4-acridine carboxamide. Cancer Res. 44 (1984) 3245-3251
6. Chourpa I., and Manfait M.J. Specific molecular interactions of acridine drugs in complexes with topoisomerase II and DNA. SERS and resonance Raman study of m-AMSA in comparison with o-AMSA. Raman Spectrosc. 26 (1995) 813-819
7. Chourpa I., Morjani H., Riou J.-F., and Manfait M. Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopy. FEBS Lett. 397 (1996) 61-64
8. Chow K.-C., MacDonald T.L., and Ross W.E. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition. Mol. Pharmacol. 34 (1988) 467-473
9. Makhey D., Yu C., Liu A., Liu L.F., and La Voie E.J. Substituted benz[a]acridines and benz[c]acridines as mammalian topoisomerase poisons. Bioorg. Med. Chem. 8 (2000) 1171-1182
10. Elomri A., Mitaku S., Michel S., Skaltsounis A., Tillequin F., Koch M., Pierré A., Guilbaud N., Léonce S., Kraus-Berthier L., Rolland Y., and Atassi G.J. Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series. J. Med. Chem. 39 (1996) 4762-4766
11. Costes N., Le Deit H., Michel S., Tillequin F., Koch M., Pfeiffer B., Renard P., Léonce S., Guilbaud N., Kraus-Berthier L., Pierré A., and Atassi G.J. Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3,2-h]acridin-7-one analogues of acronycine. J. Med. Chem. 43 (2000) 2395-2402
12. Dorr R.T., and Liddil J.D. Development of a parenteral formulation for the antitumor agent acronycine. J. Drug Dev. 1 (1988) 31-39
13. Rodríguez-Loaiza P., Quintero A., Rodríguez-Sotres R., Solano J.D., and Lira-Rocha A. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals. Eur. J. Med. Chem. 39 (2004) 5-10
14. Loza-Mejía M.A., Maldonado-Hernández K., Rodríguez-Hernández F., Rodríguez-Sotres R., González-Sánchez I., Solano J.D., and Lira-Rocha A. Synthesis, cytotoxic evaluation, and DNA binding of novel thiazolo[5,4-b]quinoline derivatives. Bioorg. Med. Chem. 16 (2008) 11421-12149
15. Chen Y.-L., Chen I.-L., Wang T.-C., Han C.-H., and Tzeng C.-C. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives. Eur. J. Med. Chem. 40 (2005) 928-934
16. Fischer G., and Pindur U. A molecular modeling study of B-DNA-intercalation complexes with amsacrine and related 9-anilino-acridines. Pharmazie 54 (1999) 83-93
17. Rajendran A., and Nair B. Unprecedented dual binding behaviour of acridine group of dye: a combined experimental and theoretical investigation for the development of anticancer chemotherapeutic agents. Biochim. Biophys. Acta 1760 (2006) 1794-1801
18. Zhang Q., and Chen E.C.M. The experimental hardness and electronegativity of the purines and pyrimidines in DNA and RNA supported by the AM1 calculation of the electron affinities and ionization potentials. Biochem. Biophys. Res. Commun. 217 (1995) 755-760
19. Miri R., Javidnia K., Sarkarzadeh H., and Hemmateenejad B. Synthesis, cytotoxicity, QSAR, and intercalation study of new diindenopyridine derivatives. Bioorg. Med. Chem. 14 (2006) 4842-4849
20. Hall D., Swann D.A., and Waters T.N. Crystal and molecular structure of 4′-(acridin-9-ylamino) methanesulphonanilide hydrochloride, a compound showing antileukemic activity. J. Chem. Soc. Perkin Trans. II (1974) 1334-1337
21. Denny W.A., Atwell G.J., and Baguley B.C. Potential antitumor agents. 39. Anilino ring geometry of amsacrine and derivatives: relationship to DNA binding and antitumor activity. J. Med. Chem. 26 (1983) 1625-1630
22. Waring M.J., and Bailly C. The purine 2-amino group as a critical recognition element for binding of small molecules to DNA. Gene 149 (1994) 69-79
23. Rehn C., and Pindur U. Molecular modeling of intercalation complexes of antitumor active 9-aminoacridine and a [d,e]-anellated isoquinoline derivative with base paired deoxytetranucleotides. Monatsh. Chem. 127 (1996) 645-648
24. Baginski M., Fogolari F., and Briggs J.M. Electrostatic and non-electrostatic contributions to the binding free energies of anthracycline antibiotics to DNA. J. Mol. Biol. 274 (1997) 253-267
25. Shui X., Peek M.E., Lipscomb L.A., Gao Q., Ogata C., Roques B.P., Garbay-Jaureguiberry C., Wilkinson A.P., and Williams L.D. Effects of cationic charge on three-dimensional structures of intercalative complexes: structure of a bis-intercalated DNA complex solved by MAD phasing. Curr. Med. Chem. 7 (2000) 59-71
26. Patterson S., Coxon J., and Strekowski L. Intercalation of ethidium and analogues with nucleic acids: a molecular orbital study. Bioorg. Med. Chem. 5 (1997) 277-281
27. Wadkins R.M., and Graves G.E. Interactions of anilinoacridines with nucleic acids: effects of substituent modifications on DNA-binding properties. Biochemistry 30 (1991) 4277-4283
28. Braga S., de Melo L., and Barone P. Semiempirical study on the electronic structure of antitumor drugs ellipticines, olivacines and isoellipticines. J. Mol. Struct. (Theochem.) 710 (2004) 51-59
29. 2: rationale for sequence-specific Hoogsteen base pairing. J. Med. Chem. 36 (1993) 1548-1561
30. Gao H., Denny W.A., Garg R., and Hansch C. Quantitative structure-activity relationships (QSAR) for 9-anilinoacridines: a comparative analysis. Chem. Biol. Interact. 116 (1998) 157-180
31. Medhi C., Mitchell J., Price S., and Tabor A. Electrostatic factors in DNA intercalation. Biopolymers (Nucleic Acids Sci.) 52 (1999) 84-93
32. Dickerson R.E. Definitions and nomenclature of nucleic acid structure components. Nucleic Acids Res. 17 (1989) 1797-1803
33. Lu X.-J., and Olson W.K. 3DNA: a software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures. Nucleic Acids Res. 31 (2003) 5108-5121
34. Olson W.K., Bansal M., Burley S.K., Dickerson R.E., Gerstein M., Harvey S.C., Heinemann U., Lu X.-J., Neidle S., Shakked Z., Sklenar H., Suzuki M., Tung C.-S., Westhof E., Wolberger C., and Berman H.M. A standard reference frame for the description of nucleic acid base-pair geometry. J. Mol. Biol. 313 (2001) 229-237
35. De Oliveira B.D., and Gáudio A.C. BuildQSAR: A new computer program for QSAR studies. Quant. Struct. -Act. Rel. 19 (2003) 599-601
36. Chen K., Gresh N., and Pullman B. Energetics and stereochemistry of DNA complexation with the antitumor AT specific intercalators tilorone and m-AMSA. Nucleic Acids Res. 16 (1988) 3061-3073
37. Zhang Z., Yang Y., Zhang D., Wang Y., Qiana X., and Liu F. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: Various DNA binding geometry and interesting antitumor capacity. Bioorg. Med. Chem. 14 (2006) 6962-6970